Clinical Trial Update: Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface. [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is planned to evaluate the safety and tolerability of PRO-190 ophthalmic solution compared with Systane Ultra for dry eye disease. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• PRO-190 ophthalmic solution
• Systane Ultra

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Dry Eye, Dry Eyes Chronic | Phase 1 | Status: NOT_YET_RECRUITING